ArticleBMC cancer2021

Pooled analysis of combination antiemetic therapy for chemotherapy-induced nausea and vomiting in patients with colorectal cancer treated with oxaliplatin-based chemotherapy of moderate emetic risk.

Mototsugu Shimokawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.